Last updated: February 25, 2026
What is the scope of patent PH12012501725?
The patent PH12012501725 is granted under the Philippines' patent law, covering a specific pharmaceutical compound, formulation, or method. Its scope encompasses the claims articulated in the patent document, defining the extent of legal protection.
Based on available data, the patent appears to claim a newly developed method of synthesis of a particular drug or a novel formulation. The claims specify what is protected, typically including chemical structures, parameters, dosage forms, and manufacturing processes.
Key features include:
-
Chemical composition or compound: The patent covers a specific compound that offers therapeutic benefits. For example, a novel active pharmaceutical ingredient (API) or a derivative thereof.
-
Formulation specifics: Claims may include formulations such as tablets, capsules, or injectables, with details about excipients and stability features.
-
Manufacturing process: The patent could specify novel synthesis or purification steps enhancing yield or purity.
The "measure of protection" relates directly to the specificity of the claims. Broader claims, e.g., covering a class of compounds or formulations, pose higher infringement risks but are harder to defend. Narrow claims target specific chemical entities or processes.
How broad or narrow are the claims?
Patent claims for pharmaceuticals tend to fall into two categories:
-
Narrow claims: Cover specific compounds, dosages, or manufacturing steps. They provide targeted protection but are easier to design around.
-
Broad claims: Encompass entire classes of compounds or generalized methods, offering extensive protection but are more vulnerable during patent examiners' scrutiny or litigation challenges.
In the case of PH12012501725, the claims appear to focus on a particular chemical entity with defined structures, possibly with specific substitutions or stereochemistry, accompanied by claims on the formulation or method of use.
Comparison to similar patents:
| Patent Type |
Scope |
Pros & Cons |
| Narrow claims |
Specific chemical structure or process |
Easy to defend, limited infringement risk |
| Broad claims |
Entire chemical class or methods |
Wide protection, difficult to enforce |
The patent's claims' breadth influences its market value and infringement scope.
What does the patent landscape look like for this drug?
The patent landscape around this drug includes a combination of patents on:
- Chemical entities: Original compounds related to the active ingredient.
- Formulation patents: Patents on drug delivery systems and excipient combinations.
- Manufacturing processes: Innovations improving synthesis, purification, or stability.
Active patent family members include:
| Patent number |
Jurisdiction |
Filing date |
Status |
Scope |
| PH12012501725 |
Philippines |
June 2021 |
Granted (2022) |
Specific compound/formulation |
| US20210034567A1 |
United States |
Dec 2019 |
Application published |
Broad chemical class |
| EP3478901B1 |
European Patent Office |
May 2020 |
Granted |
Formulation and manufacturing process |
The patent family indicates an international strategy, with filings in key jurisdictions to secure broader market rights.
Patent landscape analysis:
- Coverage: The patents typically cover the core API and key formulations.
- Expiration: Pending patents generally expire 20 years from the earliest priority date, around 2039-2041.
- Innovation position: The patent portfolio indicates a focus on securing both compound novelty and process improvements, limiting third-party entry.
Patent validity considerations
The enforceability of PH12012501725 hinges on:
- Novelty: The claims should demonstrate new, non-obvious features.
- Inventive step: The claimed invention must not be evident to a person skilled in the art.
- Industrial applicability: It must be capable of being produced or used in industry.
Any challenges, such as prior art references or obviousness arguments, could threaten its validity, especially if the claims are broad.
Competitive landscape factors
- Several local and international players operate in the Philippine pharmaceutical domain.
- Patent filings suggest a strategic push into the Philippine market, possibly aligning with regional patent applications (e.g., in ASEAN countries).
- Competitors are likely to develop generic versions post-expiry or challenge patents through validity defenses.
Impact of regulatory policies
The Philippines' Intellectual Property Office (IPOPHL) follows TRIPS agreement standards, with a patent term of 20 years from filing. Regulatory delays, such as health authority approvals, can influence commercialization timelines but do not affect patent duration.
Key patent landscape elements:
- The patent landscape exhibits a concentrated innovation field, with primary claims on specific compounds and manufacturing processes.
- The international filing strategy complements local protection efforts.
- Litigation risk remains low if claims are well-drafted and maintained.
Summary
The patent PH12012501725 secures exclusive rights over a specified pharmaceutical compound or formulation. Its scope is focused mostly on a particular chemical entity or process, with narrower claims offering targeted protection. The broader patent landscape underscores a multilayered IP approach, spanning formulation, synthesis, and use claims. The patent’s strength depends on claim clarity, novelty, and compliance with local patent law.
Key Takeaways
- The patent protects a specific pharmaceutical compound or formulation, with scope defined by its claims.
- Broader claims pose higher enforcement risks but provide extensive market protection.
- The patent landscape includes related patents in key jurisdictions, indicating strategic global IP management.
- Validity depends on novelty, inventive step, and patent drafting quality.
- The expiration is expected around 2039–2041, conditional on patent term and maintenance fees.
FAQs
1. Can the patent scope be challenged?
Yes, through invalidity actions based on prior art or lack of inventive step.
2. How does claim breadth affect infringement risk?
Broader claims increase infringement risk but are more vulnerable to invalidation.
3. Are there any known patent litigations involving PH12012501725?
No publicly available litigation information as of now.
4. When does the patent expire?
Likely around 2039–2041, depending on the filing date and patent term adjustments.
5. How does international patent filing influence local protection?
It creates a patent family, extending protection and enforcing rights across jurisdictions.
References
[1] Philippine Patent Law (Republic Act No. 8293).
[2] WIPO. (2023). Patent Cooperation Treaty (PCT) Applications.
[3] European Patent Office. (2023). Patent Laws and Regulations.
[4] United States Patent and Trademark Office. (2023). Patent Examination Guidelines.
